Simplify the Creation, Release, and Management of Multilingual Content

Reduce your cycle times and translation costs while improving resource allocation and achieving greater visibility

Learn More
tpt dig

Drive Consistency and Transparency with GlobalLink TMS

TransPerfect’s translation management system (TMS) helps leading life sciences organizations:

  • Icon Automate Manual Processes

Automate manual tasks

  • Icon Magnifying Glass with a Clock

Ensure a comprehensive audit trail, including a clear record of who made changes and when they were made

  • Icon Checklist 2

Facilitate a collaborative online review process to eliminate the need for an email with marked-up files

  • Icon AI Integrations

Centrally manage and leverage translation memory (TM) and other linguistic assets

  • Icon Data

Capture important data for reporting and KPI metrics

  • Icon Network 2

Integrate with other content repositories

Centralize your content in a web-based, intuitive, and secure platform

Streamlining processes to reduce cycle times and increase efficiency is an increasing trend within the life sciences industry. TransPerfect’s enabling translation technology platform, GlobalLink, automates manual steps, drives consistency through central translation memories (TMs) and linguistic assets, incorporates machine translation (MT) workflows, and offers real-time reporting for greater visibility and control. GlobalLink TMS streamlines the translation process and provides standardization that can accelerate the time-to-market by 40–60% and decrease translation costs by 25–40%.

GlobalLink TMS at a Glance

6 k+

Clients trust GlobalLink


50 %

Reduction in translation costs

40 %

Reduction in cycle times

50 %

Reduction of internal project management and IT dependencies

50 +

Out-of-the-box connectors for automation

Document Check

GxP and CFR 21 Part 11 compliant

Handshake

Key partnerships, including Veeva and Adobe

GlobalLink

Translation Management Technology That Supports Your Growth

Sponsors supporting global operations produce vast amounts of content in need of translation. The complexity of content volume, tight timelines, quality and compliance concerns, administrative burden, and budget constraints all challenge the efficiency of managing content translation at scale.

TransPerfect Life Sciences' TMS solutions help sponsors navigate content complexities by driving process automation, improving TM efficacy and consistency, incorporating MT workflows, and optimizing content review to shorten cycle times and reduce total translation costs.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of over 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

20230124-lifesciences-resize-v3_0022_400x160px-hologic_logo.png
untitled_design_4.png
20230124-lifesciences-resize-v3_0016_400x160px-bayer_logo.png
20230124-lifesciences-resize-v3_0015_400x160px-merck_logo.png

Learn Why Leading Life Sciences Organizations Love GlobalLink TMS

Schedule a Demo.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations involved in clinical trial management.

Is AI Ready to Transform COA Development?

AI is reshaping clinical development, but its greatest value may lie not in replacing human expertise, but rather in augmenting it. Across the drug development pipeline, AI is helping teams analyze vast datasets faster, identify promising compounds earlier, and uncover patterns that may have been missed through conventional methods alone. At the same time, not every part of clinical development is equally ready for AI-driven automation. In patient-facing areas such as ...

Is AI Ready to Transform COA Development?

AI in Medical Information: Challenges, Opportunities, and the Path to Compliant Content at Scale

Medical information teams are being asked to do more with less; faster turnaround, broader content demands, and zero tolerance for inaccuracy. AI offers a way forward, but adoption comes with real challenges: how do you validate accuracy, integrate literature review, and build ...

Xtalks | Improve Recruitment Outcomes Through More Diverse Clinical Trials

Since the advent of artificial intelligence (AI), medical device manufacturers have been early adopters for product enhancements. Now, manufacturers are evaluating their regulated content and other production processes for suitable applications of AI and automation technology. ...

Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities

The European Commission’s proposed Biotech Act introduces changes that could reshape how clinical trials are approved and managed across the EU. While the broader package spans multiple areas of the health ecosystem, proposed updates to the EU Clinical Trial Regulation (EU...

5 Common eCOA Migration Issues

With so many clinical trials now using COAs on electronic platforms, the practice of “migration” (transferring and adapting COAs for electronic use) has become more common than ever. Without careful implementation, one minor deviation can compound across many languages,...

A Checklist for eCOA Solution Deployment: Best Practices and Considerations

Selecting and deploying a new eCOA solution involves many important factors - from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration - and it’s impossible not to worry about missing a key detail in the ...

Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions

This spotlight reviews the challenges faced by a Fortune 500 pharmaceutical company in implementing Clinical Outcome Assessments (COAs) to measure the impact of their products on patients. It discusses the need for accurate and culturally appropriate translations of COAs for ...